| |
|
|
| |
|
|
| |
Reuven Schore, MD
|
|
 |
Center of Excellence, Departments, and Programs
The Center for Cancer and Blood Disorders
Oncology
Leukemia/Lymphoma Program
Patient and Family Support Program (Cancer and Blood Disorders)
Specialties: Acute Lymphoblastic Leukemia (ALL), Leukemia
|
|
| Board Certifications |
American Board of Pediatrics
American Board of Pediatrics/Hematology-Oncology
|
National Provider Identifier
 |
1033204227 |
|
| Practice Locations |
Children's National Medical Center - Main Hospital
111 Michigan Avenue, NW
Washington, DC
Phone: 202-476-5000
 
|
|
| Biography |
Reuven Schore, MD, is a pediatric oncologist and a member of the Leukemia/Lymphoma Program at Children's National Medical Center.
Dr. Schore is the vice chair for a Children's Oncology Group study investigating intravenous treatments for patients with high-risk acute lymphoblastic leukemia (ALL).
|
|
| Education |
| Type | School | Location | Degree | Field of Study | Years | | Undergraduate Education | State University of New York at Brooklyn | Brooklyn, NY | Bachelor of Arts | | 1992 -1995 | | Medical School | State University of New York at Brooklyn | Brooklyn, NY | Doctor of Medicine | | 1996 -2000 |
|
|
| Training |
| Type | Institution | Location | Position | Specialty | Years | | Internship Program | North Shore University Hospital at Manhasset | Manhasset, NY | Intern | Pediatrics | 2000 - 2001 | | Residency Program | North Shore University Hospital at Manhasset | Manhasset, NY | Resident | Pediatrics | 2001 - 2003 | | Fellowship Program | Cincinnati Children's Hospital Medical Center | Cincinnati, OH | Fellow | Pediatric Hematology/Oncology | 2003 - 2006 |
|
|
| Affiliations and Memberships |
| Title | Institution | Committee / Section | Years | | Member | American Society of Clinical Oncology | | 2003 - 2009 | | Member | American Society of Pediatric Hematology/Oncology | | 2003 - 2009 | | Member | American Society of Hematology | | 2003 - 2009 | | Member | American Academy of Pediatrics | | 2000 - 2009 |
|
|
| Research |
| Title | Study Name | Institution | Years | | Principal Investigator | Pilot Study of Intravenous EZN-2285 (SC-PEG E. coli L-asparaginase, IND# 100594) or Intravenous Oncaspar® in the Treatment of Patients with High-Risk Acute Lymphoblastic Leukemia | Children’s Oncology Group | 2008 - 2009 | | | Principal Investigator | Phase IB Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children with Neutropenia | Schering-Plough | 2008 - 2009 | | | Principal Investigator | An Open-Label Treatment Protocol For the Use of Voraxaze as Adjunctive Treatment for Patients Experiencing or at Risk of Methotrexate Toxicity | Protherics | 2007 - 2009 | |
|
|
| Publications |
Journal Article, Müller, L.W., Schore, R.J., Zheng, Y., Thomas, E.K., Kim, M.O., Cancelas, J.A., Gu, Y., and Williams, D.A. (2008), Rac Guanosine Triphosphatases represent a potential target in AML, Leukemia.
Conference Presentation - Poster, Schore, R.J., Zheng, Y., Williams, D.A., and Gu, Y. (2006), 8th Annual OSU Comprehensive Cancer Center Scientific Meeting, Poster session presented at the Inhibition of the Rho GTPase, Rac, differentially inhibits proliferation of AML cell lines and may serve as a novel molecular target, Columbus, OH
Conference Presentation - Poster, Schore, R.J., Zheng, Y., Williams, D.A., and Gu, Y. (2006), Fourth Annual Midwest Blood Club Meeting, Poster session presented at the Rac, a Member of the Rho GTPase Family, Is a Potential Target in AML, Lexington, KY
Conference Presentation - Poster, Schore, R.J., Zheng, Y., Williams, D.A., and Gu, Y. (2006), Pediatric Academic Society/American Society of Pediatric Hematology/Oncology Meeting, Poster session presented at the Rac, a Member of the Rho GTPase Family, Is a Potential Target in AML.” Pediatric Blood & Cancer , San Francisco, CA
Conference Presentation - Poster, Gu, Y., Alvares, A., Jasti, A.C., Jansen, M., Schore, R.J., Bean, J., Jegga, A.G., Aronow, B.J., and Williams, D.A. (2005), The 6th International Symposium and Expert Workshops on Leukemia and Lymphoma, Poster session presented at the Alteration of RhoH expression is associated with human diffuse large-B-cell lymphoma, Amsterdam, Netherlands
Conference Presentation - Poster, Schore, R.J., Zheng, Y., Williams, D.A., and Gu, Y. (2005), American Society of Hematology Annual Meeting, Poster session presented at the Inhibition of the Rho GTPase, Rac, differentially inhibits proliferation of AML cell lines and may serve as a novel molecular target, Atlanta, GA
For a more comprehensive list of publications for Reuven Schore, MD view the National Library of Medicine’s PubMed online database |
|
|
|
|
|
|
